Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Lung Cancer Patients

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

Journal of Thoracic Oncology ◽

10.1097/01243894-200609000-00012 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678 ◽

Cited By ~ 3

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31829cf942 ◽

2013 ◽

Vol 8 (9) ◽

pp. 1121-1127 ◽

Cited By ~ 49

Author(s):

Suzanne E. Dahlberg ◽

Joan H. Schiller ◽

Philip B. Bonomi ◽

Alan B. Sandler ◽

Julie R. Brahmer ◽

...

Keyword(s):

Lung Cancer ◽

Body Mass Index ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Lung Cancer Patients

A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(15)30380-4 ◽

2006 ◽

Vol 1 (7) ◽

pp. 673-678

Author(s):

Gregory A. Masters ◽

Sigui Li ◽

Afshin Dowlati ◽

Stefan Madajewicz ◽

Corey Langer ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Eastern Cooperative Oncology Group score: Agreement between non-small-cell lung cancer patients and their oncologists and clinical implications

Cancer Treatment Communications ◽

10.1016/j.ctrc.2015.11.009 ◽

2016 ◽

Vol 5 ◽

pp. 17-21 ◽

Cited By ~ 6

Author(s):

Ashanya Malalasekera ◽

Cindy Sim Y. Tan ◽

Viet Phan ◽

Po Yee Yip ◽

Janette Vardy ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Clinical Implications ◽

Oncology Group ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Group Score

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study

Medical and Pediatric Oncology ◽

10.1002/mpo.2950170306 ◽

1989 ◽

Vol 17 (3) ◽

pp. 197-201 ◽

Cited By ~ 10

Author(s):

David S. Ettinger ◽

Dianne M. Finkelstein ◽

Ross C. Donehower ◽

Alex Y. C. Chang ◽

Michael Green ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-014-2427-7 ◽

2014 ◽

Vol 74 (1) ◽

pp. 177-183 ◽

Cited By ~ 12

Author(s):

Rathi N. Pillai ◽

Joseph Aisner ◽

Suzanne E. Dahlberg ◽

John S. Rogers ◽

Robert S. DiPaola ◽

...

Keyword(s):

Lung Cancer ◽

Retinoic Acid ◽

Small Cell Lung Cancer ◽

Interferon Alpha ◽

Cell Lung Cancer ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer: An Eastern Cooperative Oncology Group study

Lung Cancer ◽

10.1016/0169-5002(95)96460-d ◽

1995 ◽

Vol 12 (1-2) ◽

pp. 155

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern Cooperative Oncology Group Study

Lung Cancer ◽

10.1016/0169-5002(90)90355-p ◽

1990 ◽

Vol 6 (1-2) ◽

pp. 58-59

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Long-term survivors in metastatic non-small-cell lung cancer: An eastern cooperative oncology group study

Lung Cancer ◽

10.1016/s0169-5002(87)80507-x ◽

1987 ◽

Vol 3 (1) ◽

pp. 51-52

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Long Term Survivors

Faculty Opinions recommendation of Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1097586.553672 ◽

2008 ◽

Author(s):

Jack West

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Advanced Stage ◽

Oncology Group ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Group Trial